Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-479.00M
↓ 105% below average
Average (5y)
$-234.10M
Historical baseline
Range
High:$-62.44M
Low:$-479.00M
CAGR
+50.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-479.00M | -36.8% |
| 2023 | $-350.06M | -42.5% |
| 2022 | $-245.73M | -34.4% |
| 2021 | $-182.78M | -116.0% |
| 2020 | $-84.61M | -35.5% |
| 2019 | $-62.44M | - |